CrossRef Forward Linking Search Results

This Article:

Douglas D. Richman, Terri Wrin, Susan J. Little, and Christos J. Petropoulos
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
PNAS 2003 : 63053010

has been cited by the following articles in journals that are participating in CrossRef's forward linking service:

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline
J Michael Kilby, Ha Youn Lee, J Darren Hazelwood, Anju Bansal, R Patterson Bucy, Michael S Saag, George M Shaw, Edward P Acosta, Victoria A Johnson, and Alan S Perelson
AIDS (2008) 22: 957
Link to Article
Implications from the SIV model in understanding HIV neutralization
Anna Laurén and Eva Maria Fenyö
Future HIV Therapy (2008) 2: 47
Link to Article
Anti-HIV adaptive immunity: determinants for viral persistence
Hiroyuki Yamamoto and Tetsuro Matano
Reviews in Medical Virology (2008) 18: 293
Link to Article
Toward an AIDS Vaccine
B. D. Walker and D. R. Burton
Science (2008) 320: 760
Link to Article
Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy
Florencia Pereyra, Marylyn M. Addo, Daniel E. Kaufmann, Yang Liu, Toshiyuki Miura, Almas Rathod, Brett Baker, Alicja Trocha, Rachel Rosenberg, and Elizabeth Mackey
The Journal of Infectious Diseases (2008) 197: 563
Link to Article
Loss of HIV-1-specific T-cell responses associated with very rapid HIV-1 disease progression
Hendrik Streeck, Becky Schweighardt, Heiko Jessen, Rachel L Allgaier, Terri Wrin, Eric W Stawiski, Arne B Jessen, Todd M Allen, Bruce D Walker, and Marcus Altfeld
AIDS (2007) 21: 889???891
Link to Article
Biological and Genetic Evolution of HIV Type 1 in Two Siblings with Different Patterns of Disease Progression
Chiara Ripamonti, Thomas Leitner, Anna Laurén, Ingrid Karlsson, Angela Pastore, Mariangela Cavarelli, Liselotte Antonsson, Anna Plebani, Eva Maria Fenyö, and Gabriella Scarlatti
AIDS Research and Human Retroviruses (2007) 23: 1531
Link to Article
Influence of Strain, Dose of Virus, and Age at Inoculation on Subgroup J Avian Leukosis Virus Persistence, Antibody Response, and Oncogenicity in Commercial Meat-Type Chickens
Arun R. Pandiri, Willie M. Reed, Jody K. Mays, and Aly M. Fadly
Avian Diseases (2007) 51: 725
Link to Article
HIV/AIDS Vaccines: 2007
H L Robinson
Clinical Pharmacology & Therapeutics (2007) 82: 686
Link to Article
The impact of viral and host elements on HIV fitness and disease progression
Kenneth R. Henry, Jan Weber, Miguel E. Quiñones-Mateu, and Eric J. Arts
Current HIV/AIDS Reports (2007) 4: 36
Link to Article
HIV-1 vaccine development: Progress and prospects
Anna R. Thorner and Dan H. Barouch
Current Infectious Disease Reports (2007) 9: 71
Link to Article
Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination
David C Montefiori, Lynn Morris, Guido Ferrari, and John R Mascola
Current Opinion in HIV and AIDS (2007) 2: 169
Link to Article
Humoral immunity to HIV-1: neutralization and beyond
M. Huber and A. Trkola
Journal of Internal Medicine (2007) 262: 5
Link to Article
Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge
Patricia Polacino, Brad Cleveland, Yongde Zhu, Jason T. Kimata, Julie Overbaugh, David Anderson, and Shiu-Lok Hu
Journal of Medical Primatology (2007) 36: 254
Link to Article
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell, Lars Hangartner, Meredith Hunter, Carin E. G. Havenith, Frank J. Beurskens, Joost M. Bakker, Caroline M. S. Lanigan, Gary Landucci, Donald N. Forthal, and Paul W. H. I. Parren
Nature (2007) 449: 101
Link to Article
Virological and immunological bases for HIV-1 vaccine design
Hiroyuki YAMAMOTO and Tetsuro MATANO
Uirusu (2007) 57: 133
Link to Article
Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients
Anju Bansal, Ethan Gough, Doug Ritter, Craig Wilson, Joseph Mulenga, Susan Allen, and Paul A Goepfert
AIDS (2006) 20: 353???360
Link to Article
Broad neutralization and complement-mediated lysis of HIV-1 by PEHRG214, a novel caprine anti-HIV-1 polyclonal antibody
Erin E Verity, Lisa A Williams, Da??ed N Haddad, Vernon Choy, Chris O??Loughlin, Catherine Chatfield, Nitin K Saksena, Anthony Cunningham, Frank Gelder, and Dale A McPhee
AIDS (2006) 20: 505???515
Link to Article
ERRATUM
&NA;
AIDS (2006) 20: 1093???1094
Link to Article
Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection
Vincent Vieillard, Dominique Costagliola, Anne Simon, and Patrice Debr??
AIDS (2006) 20: 1795???1804
Link to Article
Continued Evolution in gp41 after Interruption of Enfuvirtide in Subjects with Advanced HIV Type 1 Disease
Christina M.R. Kitchen, Jing Lu, Marc A. Suchard, Rebecca Hoh, Jeffrey N. Martin, Daniel R. Kuritzkes, and Steven G. Deeks
AIDS Research and Human Retroviruses (2006) 22: 1260
Link to Article
The Effects of Early Antiretroviral Therapy and Its Discontinuation on the HIV-Specific Antibody Response
M. Scott Killian, Philip J. Norris, Bhupat D. Rawal, Mila Lebedeva, Frederick M. Hecht, Jay A. Levy, and Michael P. Busch
AIDS Research and Human Retroviruses (2006) 22: 640
Link to Article
Short Communication: Antiretroviral Therapy Does Not Induce HIV Type 1-Specific Neutralizing Activity against Autologous HIV Type 1 Isolates
Claudia Devito, Bo Hejdeman, Jan Albert, Kristina Broliden, and Jorma Hinkula
AIDS Research and Human Retroviruses (2006) 22: 908
Link to Article
High Incidence of Unusual Cysteine Variants in gp120 Envelope Proteins from Early HIV Type 1 Infections from a Phase 3 Vaccine Efficacy Trial
David V. Jobes, Melissa Daoust, Vivian Nguyen, Allan Padua, Suzanne Michele, Michael D. Lock, Allen Chen, Faruk Sinangil, and Phillip W. Berman
AIDS Research and Human Retroviruses (2006) 22: 1014
Link to Article
HIV VACCINES
Andrew J. McMichael
Annual Review of Immunology (2006) 24: 227
Link to Article
Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection
Anthony D. Kelleher and John J. Zaunders
Current HIV/AIDS Reports (2006) 3: 5
Link to Article
Insights into neutralizing antibodies and HIV Envelope
Nancy L Haigwood
Current Opinion in HIV and AIDS (2006) 1: 301
Link to Article
Probing the possibilities for T-cell-based AIDS vaccines
David A Garber and Mark B Feinberg
Current Opinion in HIV and AIDS (2006) 1: 314
Link to Article
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Barton F Haynes and David C Montefiori
Expert Review of Vaccines (2006) 5: 347
Link to Article
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Barton F Haynes and David C Montefiori
Expert Review of Vaccines (2006) 5: 579
Link to Article
Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design
Georgia Tomaras, Xiaoying Shen, and Michael Greenberg
Future Virology (2006) 1: 79
Link to Article
A Pharmacokinetic-Pharmacodynamic Model to Optimize the Phase IIa Development Program of Maraviroc
Maria C. Rosario, Bill Poland, John Sullivan, Mike Westby, and Elna van der Ryst
JAIDS Journal of Acquired Immune Deficiency Syndromes (2006) 42: 183
Link to Article
Neutralization kinetics of sensitive and resistant subtype B primary human immunodeficiency virus type 1 isolates
David Davis, Helen Donners, Betty Willems, Michel Ntemgwa, Tine Vermoesen, Guido van der Groen, and Wouter Janssens
Journal of Medical Virology (2006) 78: 864
Link to Article
Distribution and three-dimensional structure of AIDS virus envelope spikes
Ping Zhu, Jun Liu, Julian Bess, Elena Chertova, Jeffrey D. Lifson, Henry Grisé, Gilad A. Ofek, Kenneth A. Taylor, and Kenneth H. Roux
Nature (2006) 441: 847
Link to Article
Antiviral antibody responses: the two extremes of a wide spectrum
Lars Hangartner, Rolf M. Zinkernagel, and Hans Hengartner
Nature Reviews Immunology (2006) 6: 231
Link to Article
Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection
George Makedonas and Michael R. Betts
Springer Seminars in Immunopathology (2006) 28: 209
Link to Article
Combination DNA plus protein HIV vaccines
Shan Lu
Springer Seminars in Immunopathology (2006) 28: 255
Link to Article
The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring
Michael B Zwick
AIDS (2005) 19: 1725???1737
Link to Article
Comparison of Whole Gene and Whole Virus Scrambled Antigen Approaches for DNA Prime and Fowlpox Virus Boost HIV Type 1 Vaccine Regimens in Macaques
Joko Pamungkas, Robert De Rose, Diah Iskandriati, Rachmitasari Noviana, Yasmina Paramastri, C. Jane Dale, Maryanne Shoobridge, C. Jill Medveczky, Ian A. Ramshaw, and Scott Thomson
AIDS Research and Human Retroviruses (2005) 21: 292
Link to Article
Progress Toward an HIV Vaccine
Norman L. Letvin
Annual Review of Medicine (2005) 56: 213
Link to Article
Primary HIV-1 infection: Diagnosis, pathogenesis, and treatment
Malini Soogoor and Eric S. Daar
Current Infectious Disease Reports (2005) 7: 147
Link to Article
Development of an AIDS vaccine: A daunting epidemiological challenge
Neal Nathanson and Bonnie J. Mathieson
European Journal of Epidemiology (2005) 20: 123
Link to Article
HIV vaccines: brief review and discussion of future directions
Karen S Slobod, Mattia Bonsignori, Scott A Brown, Xiaoyan Zhan, John Stambas, and Julia L Hurwitz
Expert Review of Vaccines (2005) 4: 305
Link to Article
DermaVir: A Novel Topical Vaccine for HIV/AIDS
Julianna Lisziewicz, Jeffrey Trocio, Lucia Whitman, Georg Varga, Jianqing Xu, Nyasha Bakare, Patrick Erbacher, Cecil Fox, Ruth Woodward, and Phil Markham
Journal of Investigative Dermatology (2005) 124: 160
Link to Article
Infection with a molecularly cloned SIVsm virus elicits high titer homologous neutralizing antibodies with heterologous neutralizing activity
M. Mahalanabis, V.M. Hirsch, and N.L. Haigwood
Journal of Medical Primatology (2005) 34: 253
Link to Article
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
Stefan H E Kaufmann and Andrew J McMichael
Nature Medicine (2005) 11: S33
Link to Article
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
Alexandra Trkola, Herbert Kuster, Peter Rusert, Beda Joos, Marek Fischer, Christine Leemann, Amapola Manrique, Michael Huber, Manuela Rehr, and Annette Oxenius
Nature Medicine (2005) 11: 615
Link to Article
Neutralizing antibodies take a swipe at HIV in vivo
David C Montefiori
Nature Medicine (2005) 11: 593
Link to Article
The host environment drives HIV-1 fitness
Tim van Opijnen and Ben Berkhout
Reviews in Medical Virology (2005) 15: 219
Link to Article
Genetic influences on HIV infection: implications for vaccine development
Miranda Z. Smith and Stephen J. Kent
Sexual Health (2005) 2: 53
Link to Article
HIV-1 virulence, fitness and replication capacity
Eric S Daar
Therapy (2005) 2: 131
Link to Article
HIV-1 virulence, fitness and replication capacity
Eric S Daar
Therapy (2005) 2: 131
Link to Article
Development of the antibody response in acute HIV-1 infection
Marl??n MI Aasa-Chapman, Anna Hayman, Philippa Newton, David Cornforth, Ian Williams, Persephone Borrow, Peter Balfe, and ??ine McKnight
AIDS (2004) 18: 371
Link to Article
Persistence of primary drug resistance among recently HIV-1 infected adults
Jason D Barbour, Frederick M Hecht, Terri Wrin, Teri J Liegler, Clarissa A Ramstead, Michael P Busch, Mark R Segal, Christos J Petropoulos, and Robert M Grant
AIDS (2004) 18: 1683
Link to Article
Seronegative infection and AIDS caused by an A2 subsubtype HIV-1
Ana R Cardoso, Cristina Gon??alves, Dulce Pascoalinho, Carla Gil, Ant??nio F Ferreira, In??s B??rtolo, and Nuno Taveira
AIDS (2004) 18: 1071
Link to Article
Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters
Krishnan Bhaskaran, Deenan Pillay, A Sarah Walker, Martin Fisher, David Hawkins, Richard Gilson, Ken McLean, and Kholoud Porter
AIDS (2004) 18: 1471
Link to Article
Substitution of HIV Type-1 Non-B env Genes in C2, a Subtype B Cassette System, Results in Functional Chimeric Viruses
Natalie N. Zheng and Rod S. Daniels
AIDS Research and Human Retroviruses (2004) 20: 964
Link to Article
Current advances in HIV vaccines
M. Patricia D’Souza, Mary Allen, Rebecca Sheets, and Margaret I. Johnston
Current HIV/AIDS Reports (2004) 1: 18
Link to Article
Primary HIV infection
Joanne Stekler and Ann C. Collier
Current HIV/AIDS Reports (2004) 1: 68
Link to Article
HIV-1 entry inhibitors: closing the front door
Brian Tomkowicz and Ronald G Collman
Expert Opinion on Therapeutic Targets (2004) 8: 65
Link to Article
Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses
Jonathan Luke Heeney
Expert Review of Vaccines (2004) 3: S53
Link to Article
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design
Indresh K Srivastava, Jeffrey B Ulmer, and Susan W Barnett
Expert Review of Vaccines (2004) 3: S33
Link to Article
Immunogen sequence: the fourth tier of AIDS vaccine design
J I Mullins, David C Nickle, Laura Heath, Allen G Rodrigo, and Gerald H Learn
Expert Review of Vaccines (2004) 3: S151
Link to Article
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
S Staprans and Mark B Feinberg
Expert Review of Vaccines (2004) 3: S5
Link to Article
Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1
Jeffrey T. Safrit, Ruth Ruprecht, Flavia Ferrantelli, Weidong Xu, Moiz Kitabwalla, Koen Van Rompay, Marta Marthas, Nancy Haigwood, John R. Mascola, and Katherine Luzuriaga
JAIDS Journal of Acquired Immune Deficiency Syndromes (2004) 35: 169
Link to Article
Kinetics of protective antibodies are determined by the viral surface antigen
Daniel D. Pinschewer, Mar Perez, Eswaraka Jeetendra, Thomas Bächi, Edit Horvath, Hans Hengartner, Michael A. Whitt, Juan Carlos de la Torre, and Rolf M. Zinkernagel
Journal of Clinical Investigation (2004) 114: 988
Link to Article
Acute HIV revisited: new opportunities for treatment and prevention
Christopher D. Pilcher, Joseph J. Eron, Shannon Galvin, Cynthia Gay, and Myron S. Cohen
Journal of Clinical Investigation (2004) 113: 937
Link to Article
Progress on new vaccine strategies against chronic viral infections
Jay A. Berzofsky, Jeffrey D. Ahlers, John Janik, John Morris, SangKon Oh, Masaki Terabe, and Igor M. Belyakov
Journal of Clinical Investigation (2004) 114: 450
Link to Article
Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication
David A. Garber, Guido Silvestri, Ashley P. Barry, Andrew Fedanov, Natalia Kozyr, Harold McClure, David C. Montefiori, Christian P. Larsen, John D. Altman, and Silvija I. Staprans
Journal of Clinical Investigation (2004) 113: 836
Link to Article
Urgently needed: a filter for the HIV-1 vaccine pipeline
John P Moore and Dennis R Burton
Nature Medicine (2004) 10: 769
Link to Article
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
Giuseppe Pantaleo and Richard A Koup
Nature Medicine (2004) 10: 806
Link to Article
Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
Emmanouil Papasavvas, Jay R. Kostman, Karam Mounzer, Robert M. Grant, Robert Gross, Cele Gallo, Livio Azzoni, Andrea Foulkes, Brian Thiel, and Maxwell Pistilli
PLoS Medicine (2004) 1: e64
Link to Article
Role of neutralizing antibodies in HIV infection
Nancy L Haigwood and Leonidas Stamatatos
AIDS (2003) 17: 67
Link to Article
Present status of human HIV vaccine development
Sandra A Calarota and David B Weiner
AIDS (2003) 17: S73
Link to Article
Progress in the development of an HIV vaccine
Edmund C Tramont and Margaret I Johnston
Expert Opinion on Emerging Drugs (2003) 8: 37
Link to Article